(Q44594955)

4 December 2017

title

Quantification of rare NPM1 mutation subtypes by digital PCR. (English)

1 reference

4 December 2017

7

Torsten Haferlach

1 reference

4 December 2017

4

Tamara Alpermann

1 reference

4 December 2017

1

Ulrike Bacher

1 reference

4 December 2017

3

Claudia Haferlach

1 reference

4 December 2017

8

Susanne Schnittger

1 reference

4 December 2017

2

Frank Dicker

1 reference

4 December 2017

Dominic Rose

5

1 reference

4 December 2017

Wolfgang Kern

series ordinal

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

18 July 2014

1 reference

British Journal of Haematology

4 December 2017

published in

1 reference

4 December 2017

volume

167

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

710-714

1 reference

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

4 December 2017

cites work

1 reference

Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations.

21 January 2018

1 reference

Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group

21 January 2018

1 reference

Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCR.

21 January 2018

1 reference

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

21 January 2018

1 reference

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

21 January 2018

1 reference

Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML.

21 January 2018

1 reference

The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.13038

1 reference

4 December 2017

1 reference